We are live on ! Find out more
MC

Mayo Clinic Portfolio holdings

AUM $2.9M
1-Year Est. Return 14.49%
This Fund
S&P 500
This Quarter Est. Return
+8.09%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.4M
AUM Growth
-$24.4M
Cap. Flow
-$31.9M
Cap. Flow %
-32.77%
Top 10 Hldgs %
99.92%
Holding
13
New
–
Increased
–
Reduced
5
Closed
2
Avg Time Held
8.8 quarters
Top 10 Avg Time Held
4.5 quarters
Top 20 Avg Time Held
5.6 quarters

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$29M
2
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$2.64M
3
EXAS icon
Exact Sciences
EXAS
+$155K
4
UBX icon
Unity Biotechnology
UBX
+$87.5K
5
TDOC icon
Teladoc Health
TDOC
+$17.1K

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.12%
2 Energy 10.54%
3 Healthcare 7.22%
4 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ACWI icon
1
iShares MSCI ACWI ETF
ACWI
$33.2B
$80M 82.12%
833,872
-312,524
-27% -$29M
2022 Q4
2 quarters
BSM icon
2
Black Stone Minerals
BSM
$3.16B
$10.3M 10.54%
643,617
– –
2019 Q4
14 quarters
ZNTL icon
3
Zentalis Pharmaceuticals
ZNTL
$239M
$5.28M 5.42%
187,143
-110,000
-37% -$2.64M
2020 Q2
12 quarters
MIRO
4
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$336K 0.34%
191,622
– –
2022 Q4
2 quarters
UBX icon
5
DELISTED
Unity Biotechnology
UBX
$316K 0.32%
124,081
-33,117
-21% -$87.5K
2019 Q4
14 quarters
EXAS icon
6
DELISTED
Exact Sciences
EXAS
$297K 0.31%
3,167
-1,984
-39% -$155K
2022 Q4
2 quarters
CLPT icon
7
ClearPoint Neuro
CLPT
$311M
$276K 0.28%
38,114
– –
2019 Q4
14 quarters
SCLX icon
8
Scilex Holding
SCLX
$19.7M
$236K 0.24%
1,209
– –
2023 Q1
1 quarter
NMTC icon
9
NeuroOne Medical Technologies
NMTC
$9.79M
$218K 0.22%
30,292
– –
2021 Q2
8 quarters
STEX icon
10
Streamex Corp
STEX
$56.4M
$126K 0.13%
10,089
– –
2019 Q4
14 quarters
EVLO
11
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$73.4K 0.08%
22,577
-1,385
-6% -$4.12K
2019 Q4
14 quarters
TDOC icon
12
Teladoc Health
TDOC
$1.08B
– –
-659
Closed -$17.1K –
VYNT
13
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
– –
-27,742
Closed -$16.1K –

Similar funds

SWS
SYSTM Wealth Solutions Chicago, Illinois $3.29M AUM 31.67% 1-Year Est. Return
PWA
Pillar Wealth Advisors West Chester, Pennsylvania $3.35M AUM 22.3% 1-Year Est. Return
CU
Cornell University New York $3.44M AUM 9.69% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return
JC
Jetstream Capital Brentwood, Tennessee $1.37M AUM
MIG
MGG Investment Group New York $1.36M AUM 20.76% 1-Year Est. Return

Mayo Clinic's Q2 2023 Portfolio in Review

As of Q2 2023, Mayo Clinic held 13 positions worth $97.4M, down 20% from $122M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Mayo Clinic withdrew a net $31.9M in Q2 2023, closing 2 positions and reducing 5 holdings. Its most notable exit was Teladoc Health, an estimated $17.1K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 86% a quarter earlier, followed by Energy and Healthcare.

  • Mayo Clinic's biggest Q2 2023 reduction was iShares MSCI ACWI ETF, cutting an estimated $29M.
  • Mayo Clinic fully exited Teladoc Health in Q2 2023, selling an estimated $17.1K.
  • Mayo Clinic's ten largest holdings make up 100% of its $97.4M portfolio in Q2 2023.
  • Mayo Clinic opened 0 new positions and closed 2 in Q2 2023.
  • Mayo Clinic's portfolio value fell 20% quarter-over-quarter to $97.4M.

Based on Mayo Clinic's 13F filing for Q2 2023, filed 9 Aug 2023.